nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.178	0.249	CbGbCtD
Olmesartan—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.104	0.145	CbGbCtD
Olmesartan—ABCC2—Mycophenolate mofetil—systemic lupus erythematosus	0.0913	0.127	CbGbCtD
Olmesartan—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0787	0.11	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.0715	0.0998	CbGbCtD
Olmesartan—ABCC2—Cyclosporine—systemic lupus erythematosus	0.0692	0.0965	CbGbCtD
Olmesartan—ABCC2—Dexamethasone—systemic lupus erythematosus	0.0456	0.0635	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0417	0.0581	CbGbCtD
Olmesartan—ABCC2—Methotrexate—systemic lupus erythematosus	0.0366	0.0511	CbGbCtD
Olmesartan—AGTR1—endothelium—systemic lupus erythematosus	0.00387	0.126	CbGeAlD
Olmesartan—AGTR1—blood plasma—systemic lupus erythematosus	0.00343	0.112	CbGeAlD
Olmesartan—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00327	0.107	CbGeAlD
Olmesartan—AGTR1—connective tissue—systemic lupus erythematosus	0.00183	0.0596	CbGeAlD
Olmesartan—SLCO1B3—lung—systemic lupus erythematosus	0.00182	0.0593	CbGeAlD
Olmesartan—AGTR1—nephron tubule—systemic lupus erythematosus	0.00177	0.0578	CbGeAlD
Olmesartan—AGTR1—Allograft Rejection—IL21—systemic lupus erythematosus	0.00162	0.0575	CbGpPWpGaD
Olmesartan—AGTR1—kidney—systemic lupus erythematosus	0.00156	0.0508	CbGeAlD
Olmesartan—Telmisartan—PPARG—systemic lupus erythematosus	0.00153	0.483	CrCbGaD
Olmesartan—AGTR1—cortex of kidney—systemic lupus erythematosus	0.00152	0.0494	CbGeAlD
Olmesartan—SLCO1B1—kidney—systemic lupus erythematosus	0.00148	0.0484	CbGeAlD
Olmesartan—AGTR1—lymphoid tissue—systemic lupus erythematosus	0.00134	0.0436	CbGeAlD
Olmesartan—AGTR1—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.00134	0.0476	CbGpPWpGaD
Olmesartan—ABCC2—nephron tubule—systemic lupus erythematosus	0.00128	0.0418	CbGeAlD
Olmesartan—AGTR1—tendon—systemic lupus erythematosus	0.00126	0.041	CbGeAlD
Olmesartan—ABCC2—kidney—systemic lupus erythematosus	0.00113	0.0367	CbGeAlD
Olmesartan—AGTR1—lung—systemic lupus erythematosus	0.0011	0.036	CbGeAlD
Olmesartan—ABCC2—cortex of kidney—systemic lupus erythematosus	0.0011	0.0357	CbGeAlD
Olmesartan—SLCO1B3—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.00105	0.0374	CbGpPWpGaD
Olmesartan—AGTR1—nervous system—systemic lupus erythematosus	0.00102	0.0333	CbGeAlD
Olmesartan—AGTR1—central nervous system—systemic lupus erythematosus	0.000983	0.0321	CbGeAlD
Olmesartan—ABCC2—tendon—systemic lupus erythematosus	0.000908	0.0296	CbGeAlD
Olmesartan—SLCO1B3—Transport of organic anions—ALB—systemic lupus erythematosus	0.000804	0.0286	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000789	0.0281	CbGpPWpGaD
Olmesartan—Losartan—ACE—systemic lupus erythematosus	0.000729	0.23	CrCbGaD
Olmesartan—SLCO1B1—Recycling of bile acids and salts—RXRA—systemic lupus erythematosus	0.000705	0.0251	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ETS1—systemic lupus erythematosus	0.000685	0.0244	CbGpPWpGaD
Olmesartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000648	0.0231	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.000622	0.0222	CbGpPWpGaD
Olmesartan—Valsartan—ALB—systemic lupus erythematosus	0.000612	0.193	CrCbGaD
Olmesartan—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000608	0.0217	CbGpPWpGaD
Olmesartan—SLCO1B3—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.000596	0.0212	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000552	0.0197	CbGpPWpGaD
Olmesartan—SLCO1B3—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000548	0.0195	CbGpPWpGaD
Olmesartan—SLCO1B1—Transport of organic anions—ALB—systemic lupus erythematosus	0.00054	0.0192	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000443	0.0158	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.000434	0.0155	CbGpPWpGaD
Olmesartan—ABCC2—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000431	0.0154	CbGpPWpGaD
Olmesartan—AGTR1—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.000411	0.0147	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000404	0.0144	CbGpPWpGaD
Olmesartan—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.0004	0.0143	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.00039	0.0139	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000385	0.0137	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.00038	0.0135	CbGpPWpGaD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000372	0.0132	CbGpPWpGaD
Olmesartan—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000368	0.0131	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.000334	0.0119	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—systemic lupus erythematosus	0.00033	0.0118	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	0.000313	0.0111	CbGpPWpGaD
Olmesartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000311	0.0111	CbGpPWpGaD
Olmesartan—Losartan—ALB—systemic lupus erythematosus	0.000299	0.0943	CrCbGaD
Olmesartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000298	0.0106	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000298	0.0106	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CD40LG—systemic lupus erythematosus	0.000295	0.0105	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL10—systemic lupus erythematosus	0.000295	0.0105	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL4—systemic lupus erythematosus	0.000287	0.0102	CbGpPWpGaD
Olmesartan—AGTR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000281	0.01	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—FASLG—systemic lupus erythematosus	0.000275	0.00978	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—FAS—systemic lupus erythematosus	0.000265	0.00943	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2RA—systemic lupus erythematosus	0.000263	0.00937	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic lupus erythematosus	0.000262	0.00935	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—C3—systemic lupus erythematosus	0.000261	0.0093	CbGpPWpGaD
Olmesartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000259	0.00924	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	0.000238	0.00847	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000225	0.00802	CbGpPWpGaD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000225	0.008	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—CD80—systemic lupus erythematosus	0.00022	0.00782	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—systemic lupus erythematosus	0.00021	0.00747	CbGpPWpGaD
Olmesartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000209	0.00745	CbGpPWpGaD
Olmesartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.0002	0.00714	CbGpPWpGaD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.000193	0.00688	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000192	0.00686	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000182	0.0065	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IFNG—systemic lupus erythematosus	0.000174	0.00619	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000163	0.00581	CbGpPWpGaD
Olmesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—systemic lupus erythematosus	0.000162	0.00577	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000161	0.00574	CbGpPWpGaD
Olmesartan—AGTR1—Allograft Rejection—IL2—systemic lupus erythematosus	0.000154	0.0055	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000151	0.00539	CbGpPWpGaD
Olmesartan—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.000671	CcSEcCtD
Olmesartan—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000671	CcSEcCtD
Olmesartan—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000147	0.000666	CcSEcCtD
Olmesartan—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000147	0.000663	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000147	0.00522	CbGpPWpGaD
Olmesartan—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000146	0.000661	CcSEcCtD
Olmesartan—Myalgia—Betamethasone—systemic lupus erythematosus	0.000146	0.000661	CcSEcCtD
Olmesartan—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000146	0.00066	CcSEcCtD
Olmesartan—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000146	0.00066	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—systemic lupus erythematosus	0.000146	0.000659	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000146	0.000659	CcSEcCtD
Olmesartan—Discomfort—Betamethasone—systemic lupus erythematosus	0.000144	0.000654	CcSEcCtD
Olmesartan—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000144	0.000654	CcSEcCtD
Olmesartan—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000144	0.000653	CcSEcCtD
Olmesartan—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000144	0.000652	CcSEcCtD
Olmesartan—Pain—Prednisolone—systemic lupus erythematosus	0.000144	0.00065	CcSEcCtD
Olmesartan—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000143	0.000647	CcSEcCtD
Olmesartan—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000645	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000142	0.000645	CcSEcCtD
Olmesartan—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.000644	CcSEcCtD
Olmesartan—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000142	0.000644	CcSEcCtD
Olmesartan—Nausea—Leflunomide—systemic lupus erythematosus	0.000142	0.000643	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000142	0.000641	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000142	0.000641	CcSEcCtD
Olmesartan—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000141	0.00064	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—systemic lupus erythematosus	0.000141	0.000638	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000141	0.000637	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000141	0.000637	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00014	0.000635	CcSEcCtD
Olmesartan—Pain—Hydrocortisone—systemic lupus erythematosus	0.00014	0.000635	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—systemic lupus erythematosus	0.00014	0.000634	CcSEcCtD
Olmesartan—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.00014	0.000634	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.00014	0.000634	CcSEcCtD
Olmesartan—Oedema—Betamethasone—systemic lupus erythematosus	0.00014	0.000634	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00014	0.000632	CcSEcCtD
Olmesartan—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000139	0.000631	CcSEcCtD
Olmesartan—Infection—Betamethasone—systemic lupus erythematosus	0.000139	0.00063	CcSEcCtD
Olmesartan—Infection—Dexamethasone—systemic lupus erythematosus	0.000139	0.00063	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000139	0.000628	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000138	0.000626	CcSEcCtD
Olmesartan—Anaemia—Prednisone—systemic lupus erythematosus	0.000138	0.000625	CcSEcCtD
Olmesartan—Shock—Betamethasone—systemic lupus erythematosus	0.000138	0.000624	CcSEcCtD
Olmesartan—Shock—Dexamethasone—systemic lupus erythematosus	0.000138	0.000624	CcSEcCtD
Olmesartan—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000137	0.000622	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000137	0.000622	CcSEcCtD
Olmesartan—Agitation—Prednisone—systemic lupus erythematosus	0.000137	0.000622	CcSEcCtD
Olmesartan—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000137	0.000621	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000137	0.000621	CcSEcCtD
Olmesartan—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000137	0.000619	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000137	0.000619	CcSEcCtD
Olmesartan—Angioedema—Prednisone—systemic lupus erythematosus	0.000137	0.000618	CcSEcCtD
Olmesartan—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000136	0.000615	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000136	0.000614	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000135	0.000613	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000135	0.000613	CcSEcCtD
Olmesartan—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000135	0.000612	CcSEcCtD
Olmesartan—Malaise—Prednisone—systemic lupus erythematosus	0.000135	0.00061	CcSEcCtD
Olmesartan—Vertigo—Prednisone—systemic lupus erythematosus	0.000134	0.000608	CcSEcCtD
Olmesartan—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000134	0.000607	CcSEcCtD
Olmesartan—Syncope—Prednisone—systemic lupus erythematosus	0.000134	0.000607	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—systemic lupus erythematosus	0.000134	0.000604	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000134	0.000604	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—systemic lupus erythematosus	0.000133	0.000604	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000133	0.000602	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000133	0.000601	CcSEcCtD
Olmesartan—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000132	0.000599	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000132	0.00471	CbGpPWpGaD
Olmesartan—Pain—Triamcinolone—systemic lupus erythematosus	0.000132	0.000598	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000131	0.000595	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—VEGFA—systemic lupus erythematosus	0.000131	0.00467	CbGpPWpGaD
Olmesartan—Hypotension—Betamethasone—systemic lupus erythematosus	0.000131	0.000592	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000131	0.000592	CcSEcCtD
Olmesartan—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000131	0.000591	CcSEcCtD
Olmesartan—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.00013	0.00059	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—systemic lupus erythematosus	0.00013	0.000589	CcSEcCtD
Olmesartan—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00013	0.000587	CcSEcCtD
Olmesartan—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00013	0.000587	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00013	0.00461	CbGpPWpGaD
Olmesartan—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000129	0.000585	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000129	0.00461	CbGpPWpGaD
Olmesartan—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.000584	CcSEcCtD
Olmesartan—ABCC2—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000128	0.00456	CbGpPWpGaD
Olmesartan—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000128	0.000578	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000128	0.000578	CcSEcCtD
Olmesartan—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.000576	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—systemic lupus erythematosus	0.000127	0.000576	CcSEcCtD
Olmesartan—Myalgia—Prednisone—systemic lupus erythematosus	0.000127	0.000576	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000127	0.000576	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000575	CcSEcCtD
Olmesartan—Anxiety—Prednisone—systemic lupus erythematosus	0.000127	0.000574	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—systemic lupus erythematosus	0.000127	0.000574	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000127	0.000573	CcSEcCtD
Olmesartan—Insomnia—Betamethasone—systemic lupus erythematosus	0.000127	0.000573	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000127	0.00451	CbGpPWpGaD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000126	0.000572	CcSEcCtD
Olmesartan—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000126	0.000571	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000126	0.00057	CcSEcCtD
Olmesartan—Discomfort—Prednisone—systemic lupus erythematosus	0.000126	0.000569	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000126	0.000569	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000125	0.000565	CcSEcCtD
Olmesartan—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000123	0.000558	CcSEcCtD
Olmesartan—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000123	0.000558	CcSEcCtD
Olmesartan—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000557	CcSEcCtD
Olmesartan—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000123	0.000555	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000122	0.000554	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000122	0.000552	CcSEcCtD
Olmesartan—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000122	0.000552	CcSEcCtD
Olmesartan—Oedema—Prednisone—systemic lupus erythematosus	0.000122	0.000552	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000122	0.000552	CcSEcCtD
Olmesartan—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000122	0.000551	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000122	0.000551	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000122	0.000551	CcSEcCtD
Olmesartan—Infection—Prednisone—systemic lupus erythematosus	0.000121	0.000549	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000121	0.000547	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000121	0.000547	CcSEcCtD
Olmesartan—Back pain—Methotrexate—systemic lupus erythematosus	0.000121	0.000547	CcSEcCtD
Olmesartan—Fatigue—Betamethasone—systemic lupus erythematosus	0.000121	0.000547	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000121	0.000547	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—TGFB1—systemic lupus erythematosus	0.00012	0.00429	CbGpPWpGaD
Olmesartan—Shock—Prednisone—systemic lupus erythematosus	0.00012	0.000543	CcSEcCtD
Olmesartan—Pain—Dexamethasone—systemic lupus erythematosus	0.00012	0.000542	CcSEcCtD
Olmesartan—Pain—Betamethasone—systemic lupus erythematosus	0.00012	0.000542	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00012	0.000542	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—systemic lupus erythematosus	0.000119	0.000539	CcSEcCtD
Olmesartan—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000539	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—systemic lupus erythematosus	0.000119	0.000536	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000118	0.000534	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000118	0.000533	CcSEcCtD
Olmesartan—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000532	CcSEcCtD
Olmesartan—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000117	0.000531	CcSEcCtD
Olmesartan—Rash—Cyclosporine—systemic lupus erythematosus	0.000116	0.000527	CcSEcCtD
Olmesartan—Anorexia—Prednisone—systemic lupus erythematosus	0.000116	0.000526	CcSEcCtD
Olmesartan—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000116	0.000526	CcSEcCtD
Olmesartan—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000525	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000116	0.000525	CcSEcCtD
Olmesartan—Headache—Cyclosporine—systemic lupus erythematosus	0.000116	0.000523	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—systemic lupus erythematosus	0.000116	0.000523	CcSEcCtD
Olmesartan—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000115	0.000523	CcSEcCtD
Olmesartan—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000115	0.000523	CcSEcCtD
Olmesartan—AGTR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000115	0.0041	CbGpPWpGaD
Olmesartan—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000115	0.000518	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000115	0.000518	CcSEcCtD
Olmesartan—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.000518	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.000114	0.00404	CbGpPWpGaD
Olmesartan—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.000514	CcSEcCtD
Olmesartan—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.000513	CcSEcCtD
Olmesartan—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000113	0.00051	CcSEcCtD
Olmesartan—Malaise—Methotrexate—systemic lupus erythematosus	0.000113	0.00051	CcSEcCtD
Olmesartan—AGTR1—Allograft Rejection—TNF—systemic lupus erythematosus	0.000112	0.004	CbGpPWpGaD
Olmesartan—Vertigo—Methotrexate—systemic lupus erythematosus	0.000112	0.000508	CcSEcCtD
Olmesartan—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000508	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000112	0.000506	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000111	0.000504	CcSEcCtD
Olmesartan—Urticaria—Betamethasone—systemic lupus erythematosus	0.000111	0.000504	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000111	0.000503	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—systemic lupus erythematosus	0.000111	0.000502	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000111	0.000501	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000111	0.000501	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000111	0.000501	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000111	0.000501	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000111	0.000501	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000111	0.0005	CcSEcCtD
Olmesartan—Insomnia—Prednisone—systemic lupus erythematosus	0.00011	0.000499	CcSEcCtD
Olmesartan—Nausea—Cyclosporine—systemic lupus erythematosus	0.00011	0.000496	CcSEcCtD
Olmesartan—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000109	0.000494	CcSEcCtD
Olmesartan—Cough—Methotrexate—systemic lupus erythematosus	0.000109	0.000493	CcSEcCtD
Olmesartan—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000493	CcSEcCtD
Olmesartan—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000491	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000107	0.000486	CcSEcCtD
Olmesartan—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000107	0.000484	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000106	0.000481	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—systemic lupus erythematosus	0.000106	0.000481	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—systemic lupus erythematosus	0.000106	0.000481	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000106	0.00048	CcSEcCtD
Olmesartan—Rash—Prednisolone—systemic lupus erythematosus	0.000106	0.000479	CcSEcCtD
Olmesartan—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000106	0.000479	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000106	0.000478	CcSEcCtD
Olmesartan—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000477	CcSEcCtD
Olmesartan—Fatigue—Prednisone—systemic lupus erythematosus	0.000105	0.000476	CcSEcCtD
Olmesartan—Headache—Prednisolone—systemic lupus erythematosus	0.000105	0.000476	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—systemic lupus erythematosus	0.000105	0.000476	CcSEcCtD
Olmesartan—Constipation—Prednisone—systemic lupus erythematosus	0.000104	0.000472	CcSEcCtD
Olmesartan—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000472	CcSEcCtD
Olmesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000104	0.00369	CbGpPWpGaD
Olmesartan—Rash—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000468	CcSEcCtD
Olmesartan—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000468	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000103	0.00366	CbGpPWpGaD
Olmesartan—Headache—Hydrocortisone—systemic lupus erythematosus	0.000103	0.000465	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000102	0.000462	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000102	0.000461	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000461	CcSEcCtD
Olmesartan—Infection—Methotrexate—systemic lupus erythematosus	0.000101	0.000458	CcSEcCtD
Olmesartan—AGTR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000101	0.0036	CbGpPWpGaD
Olmesartan—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000101	0.000455	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000101	0.000455	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—systemic lupus erythematosus	0.000101	0.000455	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.0001	0.000453	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	9.99e-05	0.000452	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	9.98e-05	0.000452	CcSEcCtD
Olmesartan—Nausea—Prednisolone—systemic lupus erythematosus	9.98e-05	0.000451	CcSEcCtD
Olmesartan—Pruritus—Betamethasone—systemic lupus erythematosus	9.92e-05	0.000449	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—systemic lupus erythematosus	9.92e-05	0.000449	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—systemic lupus erythematosus	9.91e-05	0.000448	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	9.86e-05	0.00351	CbGpPWpGaD
Olmesartan—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	9.86e-05	0.000446	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—systemic lupus erythematosus	9.82e-05	0.000444	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.8e-05	0.000443	CcSEcCtD
Olmesartan—Nausea—Hydrocortisone—systemic lupus erythematosus	9.74e-05	0.000441	CcSEcCtD
Olmesartan—Rash—Triamcinolone—systemic lupus erythematosus	9.74e-05	0.000441	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—systemic lupus erythematosus	9.73e-05	0.00044	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—systemic lupus erythematosus	9.72e-05	0.00044	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—systemic lupus erythematosus	9.72e-05	0.00044	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—systemic lupus erythematosus	9.71e-05	0.000439	CcSEcCtD
Olmesartan—Urticaria—Prednisone—systemic lupus erythematosus	9.7e-05	0.000439	CcSEcCtD
Olmesartan—Headache—Triamcinolone—systemic lupus erythematosus	9.68e-05	0.000438	CcSEcCtD
Olmesartan—Headache—Methylprednisolone—systemic lupus erythematosus	9.65e-05	0.000437	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—systemic lupus erythematosus	9.65e-05	0.000437	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—systemic lupus erythematosus	9.65e-05	0.000437	CcSEcCtD
Olmesartan—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.59e-05	0.000434	CcSEcCtD
Olmesartan—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.59e-05	0.000434	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000431	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.29e-05	0.00042	CcSEcCtD
Olmesartan—Dizziness—Betamethasone—systemic lupus erythematosus	9.27e-05	0.000419	CcSEcCtD
Olmesartan—Dizziness—Dexamethasone—systemic lupus erythematosus	9.27e-05	0.000419	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—systemic lupus erythematosus	9.23e-05	0.000417	CcSEcCtD
Olmesartan—Nausea—Triamcinolone—systemic lupus erythematosus	9.17e-05	0.000415	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—systemic lupus erythematosus	9.15e-05	0.000414	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—systemic lupus erythematosus	8.98e-05	0.000406	CcSEcCtD
Olmesartan—Vomiting—Dexamethasone—systemic lupus erythematosus	8.91e-05	0.000403	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—systemic lupus erythematosus	8.91e-05	0.000403	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	8.88e-05	0.00316	CbGpPWpGaD
Olmesartan—Decreased appetite—Methotrexate—systemic lupus erythematosus	8.87e-05	0.000401	CcSEcCtD
Olmesartan—Rash—Betamethasone—systemic lupus erythematosus	8.84e-05	0.0004	CcSEcCtD
Olmesartan—Rash—Dexamethasone—systemic lupus erythematosus	8.84e-05	0.0004	CcSEcCtD
Olmesartan—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.83e-05	0.000399	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—systemic lupus erythematosus	8.83e-05	0.000399	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.81e-05	0.000398	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—systemic lupus erythematosus	8.79e-05	0.000398	CcSEcCtD
Olmesartan—Headache—Dexamethasone—systemic lupus erythematosus	8.78e-05	0.000397	CcSEcCtD
Olmesartan—Headache—Betamethasone—systemic lupus erythematosus	8.78e-05	0.000397	CcSEcCtD
Olmesartan—Asthenia—Prednisone—systemic lupus erythematosus	8.76e-05	0.000396	CcSEcCtD
Olmesartan—Pain—Methotrexate—systemic lupus erythematosus	8.72e-05	0.000395	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	8.67e-05	0.00309	CbGpPWpGaD
Olmesartan—Pruritus—Prednisone—systemic lupus erythematosus	8.64e-05	0.000391	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—systemic lupus erythematosus	8.41e-05	0.00038	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—systemic lupus erythematosus	8.35e-05	0.000378	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.34e-05	0.000377	CcSEcCtD
Olmesartan—Nausea—Betamethasone—systemic lupus erythematosus	8.32e-05	0.000377	CcSEcCtD
Olmesartan—Nausea—Dexamethasone—systemic lupus erythematosus	8.32e-05	0.000377	CcSEcCtD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	8.32e-05	0.00297	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	8.28e-05	0.00295	CbGpPWpGaD
Olmesartan—Urticaria—Methotrexate—systemic lupus erythematosus	8.1e-05	0.000367	CcSEcCtD
Olmesartan—Dizziness—Prednisone—systemic lupus erythematosus	8.07e-05	0.000365	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.06e-05	0.000365	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.06e-05	0.000365	CcSEcCtD
Olmesartan—Vomiting—Prednisone—systemic lupus erythematosus	7.76e-05	0.000351	CcSEcCtD
Olmesartan—Rash—Prednisone—systemic lupus erythematosus	7.7e-05	0.000348	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—systemic lupus erythematosus	7.69e-05	0.000348	CcSEcCtD
Olmesartan—Headache—Prednisone—systemic lupus erythematosus	7.65e-05	0.000346	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	7.62e-05	0.00271	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	7.52e-05	0.00268	CbGpPWpGaD
Olmesartan—Asthenia—Methotrexate—systemic lupus erythematosus	7.32e-05	0.000331	CcSEcCtD
Olmesartan—Nausea—Prednisone—systemic lupus erythematosus	7.25e-05	0.000328	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000326	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—systemic lupus erythematosus	6.98e-05	0.000316	CcSEcCtD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	6.79e-05	0.00242	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	6.76e-05	0.00241	CbGpPWpGaD
Olmesartan—Dizziness—Methotrexate—systemic lupus erythematosus	6.75e-05	0.000305	CcSEcCtD
Olmesartan—AGTR1—GPCR ligand binding—C3—systemic lupus erythematosus	6.61e-05	0.00235	CbGpPWpGaD
Olmesartan—Vomiting—Methotrexate—systemic lupus erythematosus	6.49e-05	0.000293	CcSEcCtD
Olmesartan—Rash—Methotrexate—systemic lupus erythematosus	6.43e-05	0.000291	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—systemic lupus erythematosus	6.43e-05	0.000291	CcSEcCtD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.4e-05	0.00228	CbGpPWpGaD
Olmesartan—Headache—Methotrexate—systemic lupus erythematosus	6.39e-05	0.000289	CcSEcCtD
Olmesartan—Nausea—Methotrexate—systemic lupus erythematosus	6.06e-05	0.000274	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.03e-05	0.00215	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—F2—systemic lupus erythematosus	5.8e-05	0.00207	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.73e-05	0.00204	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.57e-05	0.00199	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	5.2e-05	0.00185	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	5.17e-05	0.00184	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.06e-05	0.0018	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NAT2—systemic lupus erythematosus	4.79e-05	0.00171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.72e-05	0.00168	CbGpPWpGaD
Olmesartan—ABCC2—NRF2 pathway—TGFB1—systemic lupus erythematosus	4.6e-05	0.00164	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.59e-05	0.00163	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.44e-05	0.00158	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.3e-05	0.00153	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.2e-05	0.00149	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.1e-05	0.00146	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSK—systemic lupus erythematosus	4.09e-05	0.00146	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	4.07e-05	0.00145	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.05e-05	0.00144	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.03e-05	0.00144	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.85e-05	0.00137	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.82e-05	0.00136	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.8e-05	0.00136	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.76e-05	0.00134	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.74e-05	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.73e-05	0.00133	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—LYN—systemic lupus erythematosus	3.72e-05	0.00132	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.66e-05	0.0013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.64e-05	0.0013	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.47e-05	0.00124	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.42e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.42e-05	0.00122	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—C3—systemic lupus erythematosus	3.39e-05	0.00121	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.28e-05	0.00117	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.25e-05	0.00116	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	3.22e-05	0.00115	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.99e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.99e-05	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2—systemic lupus erythematosus	2.98e-05	0.00106	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.93e-05	0.00105	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.79e-05	0.000993	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRL—systemic lupus erythematosus	2.7e-05	0.000963	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	2.68e-05	0.000956	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.65e-05	0.000945	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.56e-05	0.000911	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.49e-05	0.000887	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.41e-05	0.000858	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.33e-05	0.000829	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.3e-05	0.000819	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.21e-05	0.000786	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.19e-05	0.000779	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.16e-05	0.00077	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.05e-05	0.00073	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.02e-05	0.000719	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.01e-05	0.000716	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	2e-05	0.000714	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—C3—systemic lupus erythematosus	2e-05	0.000713	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	1.8e-05	0.000642	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2—systemic lupus erythematosus	1.76e-05	0.000626	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	1.69e-05	0.000604	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD80—systemic lupus erythematosus	1.69e-05	0.0006	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.67e-05	0.000596	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.57e-05	0.000558	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	1.52e-05	0.000543	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	1.46e-05	0.000519	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.42e-05	0.000507	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.4e-05	0.000498	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	1.33e-05	0.000475	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.21e-05	0.000431	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—systemic lupus erythematosus	1.18e-05	0.000422	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.18e-05	0.00042	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	1.14e-05	0.000406	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.12e-05	0.000399	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.12e-05	0.000398	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	1.11e-05	0.000395	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EP300—systemic lupus erythematosus	1.06e-05	0.000378	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	1.02e-05	0.000365	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.01e-05	0.000358	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	9.79e-06	0.000349	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.24e-06	0.000329	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	8.96e-06	0.000319	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	7.45e-06	0.000265	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—systemic lupus erythematosus	6.96e-06	0.000248	CbGpPWpGaD
